CEPHALOSPORINS
Indications |
Respiratory, UTI, skin/bone infections, septicemia, gonorrhea, bacterial meningitis |
AE |
Hypersensitivity, NVD, pain at IM injection site |
1st GENERATION CEPHALOSPORINS
CEPHALEXIN |
CEFAZOLIN |
Only 1st gen parenteral still used Long T½ Surgical prophylaxis, UTI, SSTI |
Act as penicillin G substitutes and have activity against Proteus mirabilis, E. coli, and Klebsiella pneumoniae (PEcK)
2ND GENENRATION CEPHALOSPORINS
CEFUROXIME |
CEFOXITIN |
CEFOTETAN |
AE: hypoprothrominemia, disulfiram-like rxns with ethanol |
CEFONICID |
CEFAMANDOLE |
AE: hypoprothrominemia, disulfiram-like rxns with ethanol |
Indication: community-acquired infections of the respiratory tract (H. influenzae, Moraxella catarrhalis, S. pneumoniae) and UTI (Escherichia coli)
3RD GENERATION CEPHALOSPORINI
CEFIXIME |
Useful activity against B. fragilis |
CEFDINIR |
Useful activity against B. fragilis |
CEFTAZIDIME |
CEFOXATIME |
CEFTRIAXONE |
Penetrate CNS and used to treat meningitis caused by gram-negative rods except L. monocytogenes Indication: Useful activity genital, anal, and pharyngeal penicillin-resistant N. gonorrhoeae |
CEFOTAXIME |
Penetrate CNS and used to treat meningitis caused by gram-negative rods except L. monocytogenes |
CEFOPERAZONE |
AE: hypoprothrominemia, disulfiram-like rxns with ethanol |
Indications: Hospital-acquired gram-negative bacteremia
|
|
4TH GENERATION CEPHALOSPORIN
CEFIPIME |
Only one in the US, penetrates CNS |
5TH GENERATION CEPHALOSPORIN
CEFTAROLINE |
CEFTOBIPROLE |
metabolized in plasma, majority excreted in urine |
CARBAPENEMS
DORIPENEM |
IMIPINEM-CILASTIN |
Inactivated by dehydropeptidases in renal tubes |
MEROPENEM |
Greater activity against gram negative aerobes and less activity against gram positives compared to imipenem |
ERTAPENEM |
Indications : infections resistant to other drugs, enterbacter infections, extended spectrum B lactam producing gram negatives
PK: penetrates CNS, cleared by kidney
MONOBACTAMS
AZTREONAM |
Indications: pts allergic to penicillins and/or cephalosporins to treat pneumonia, meningitis, and sepsis, penetrates CNS |
No activity against gram-positive organisms
BACITRACIN (topical)
MOA |
Inhibits cell wall formation by interference with the dephosphorylation of the C55-isoprenyl pyrophosphate, a molecule that carries the building-blocks of the peptidoglycan bacterial cell wall |
Indications |
Highly nephrotoxic when administered systemically and is thus used topically for gram positive cocci and bacilli skin infections |
CYCLOSERINE
MOA |
Structural analog of D-alanine and inhibits the incorporation of D-alanine into peptidoglycan pentapeptide chain |
Indications |
Treats tuberculosis |
Toxicity |
Serious dose-related CNS toxicity |
GLYCOPEPTIDES
VANCOMYCIN |
Resistance in enterococci develops due to modification in binding site (D-ala-D-ala D-lactate) and increased numbers of D-ala-D-ala residues (S. aureus) Effective against gram positive producing lactamases and those resistant to nafcillin and methacillin (MRSA, MRSE) or allergic to penicillin or cephalosporin Indications: infections caused by MRSA (sepsis, endocarditis), penicillin-resistant enterococci, individuals with prosthetic heart valve, oral administration of antibiotic induced colitis due to C. diff SE: fever, chills, phlebitis |
VANCO + GENT |
Use: enterococcal endocarditis (penicillin allergy) |
VANCO + CEFTRIAXONE VANCO + CEFOTAXIME VANCO + RIFAMPIN |
Use: meningitis (penicillin-resistant strain of pneuomococcus |
TELAVANCIN |
Two mechanisms of action; first is the same as vancomycin and the second is it disrupts the bacterial cell membrane potential and increases membrane permeability t1/2 is 8 hours allowing for daily dosing Teratogenic |
DAPTOMYCIN |
Long half life of 6-11 days allows for weekly dosing Methicillin-susceptible and methicillin-resistant Streptococcus pneumoniae, Streptococcus pyogenes, Corynebacterium jeikeium, E. faecalis and E. faecium (including VRE) Indications: skin infections and bacteremia caused by S. aureus AE: constipation, nausea, HA, insomnia |
FOSFOMYCIN |
MOA: inhibits UDP-N acetylglucosamine 3-Enolpyruvte transferase Indications: UTI |
|
Created By
Metadata
Comments
No comments yet. Add yours below!
Add a Comment
More Cheat Sheets by olkimmilo